Xella Health

What Xella Health does

Xella Health is a women's precision health company that operates a direct-to-consumer platform combining multi-omic biomarker testing with AI-powered analysis and clinician-guided care. Its core product, sold as a $499 annual membership, screens for 130+ female-specific conditions by analyzing 100+ biomarkers across 10 health domains including hormonal, cardiovascular, metabolic, inflammatory, bone health, and stress response markers. The platform is built around the thesis that standard women's healthcare is reactive, fragmented, and often adapted from male-dominated clinical reference data; Xella positions its AI models as purpose-built for female physiology across reproductive life stages, processing 1 billion+ data points to detect patterns and predict risk earlier than conventional single-test approaches.

Under the hood, Xella's technology stack is multi-modal: a CLIA-certified and CAP-accredited dry lab processes samples collected through partnerships with Quest Diagnostics and LabCorp at 2,000+ nationwide blood draw locations, with an optional mobile phlebotomy add-on ($105). Samples are analyzed across genomic, transcriptomic, proteomic, metabolomic, and hormonal layers, with the company also integrating menstrual fluid testing alongside blood work. AI capabilities include predictive risk modeling, natural language interpretation of biomarker results, a recommendation engine for personalized care plans, and longitudinal pattern detection across repeated annual tests. A 24/7 AI Health Companion provides on-demand guidance, and clinicians can prescribe medications including hormone therapies, fertility medications, GLP-1s, and thyroid medications when clinically appropriate.

The business model is a recurring subscription anchored on the $499 annual core membership, augmented by modular Life-Stage Focus add-ons ($59 for Reproductive Age & Hormonal, $129 for Perimenopause, $299 for Preconception & Fertility), with prescription revenue, additional consults ($20–$40), and mobile phlebotomy ($105) as secondary streams. The company is headquartered in San Francisco, was founded in 2023 by former Mammoth Biosciences executives Kelly Lacob (CEO), Adriana Dantas (COO), and Jesus Ching (CTO), and publicly launched in June 2026 after raising $4.7 million in pre-seed and angel funding from Precursor Ventures, Capital F, Ulu Ventures, and Swizzle Ventures. Geographic coverage is 48 U.S. states at launch with planned expansion to New York and New Jersey in 2027. The company is structured as a Delaware Public Benefit Corporation and has assembled a clinical advisory board including Stanford and Kindbody leadership.

Name

Xella Health

Legal name

Xella Health, PBC

Website

https://joinxella.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Xella Health is a women's precision health platform that combines multi-omic biomarker testing (100+ markers across 10 health domains) with AI-powered risk profiling and clinician oversight, sold as a $499 annual membership to individual women across 48 U.S. states.

Ownership category

akta.pro rank

Product category

Women's Precision Health Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Healthcare & Wellness Personalization (HDAAAGAI)

Keywords

• Women's precision health
• Multi-omic biomarker testing
• Fertility diagnostic services
• Perimenopause health platform
• AI health companion

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Annual Membership Subscription: Core revenue stream from $499 annual membership providing comprehensive biomarker testing, clinician consultations, AI-powered insights, and personalized care plans.
2. Life-Stage Focus Add-ons: Optional specialized lab panels including Reproductive Age ($59), Perimenopause ($129), Preconception & Fertility ($299). Additional async consults and extended care visits available as add-ons.
3. Prescription Medications: Clinicians can prescribe medications when clinically appropriate including hormone therapies, fertility medications, GLP-1s, thyroid medications. Compounded medications available through Xella's pharmacy partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Xella Health sells an annual precision health membership priced at $499 that bundles comprehensive multi-omic biomarker lab testing (100+ biomarkers across 10 health domains), AI-powered biomarker interpretation with clinician review, screening for 130+ female-specific conditions, and personalized care plans delivered through asynchronous clinician consultations. The core membership is supplemented by modular life-stage add-on lab panels (Reproductive Age, Perimenopause, Preconception & Fertility), on-demand mobile phlebotomy, and prescription services through partner pharmacies.

Product overview

Xella Health is a precision health platform designed specifically for women's health, combining comprehensive multi-omic diagnostics with AI-powered analysis and clinician-guided care. The core offering is the Xella Health Core Membership at $499 annually, which includes a Core Lab Panel analyzing 105 biomarkers across 10 health domains, AI-powered biomarker interpretation, screening for 130+ conditions, and personalized care plans with clinician oversight. The platform offers modular Life-Stage Focus add-ons (Reproductive Age at $59, Perimenopause at $129, Preconception & Fertility at $299), Mobile Phlebotomy service ($105), and an upcoming Deeper Multi-Omic Testing add-on. The platform analyzes over 1 billion data points using machine learning built specifically for female biology, integrating genomics, proteomics, metabolomics, and hormone data to provide insights across fertility, hormonal health, chronic conditions, and preventive care.

Differentiator

Problem solved

Functional benefit

Products and services

• Xella Health Core Membership Annual precision health membership priced at $499 that includes comprehensive multi-omic lab testing (100+ biomarkers), AI-powered insights with clinician review, screening for 130+ female-specific conditions, one standard async consult, one follow-up consult, prescription refills, unlimited messaging with care team, a personalized health dashboard, and personalized care plans. Designed for individual women consumers seeking precision women's healthcare.
• Life-Stage Focus: Reproductive Age & Hormonal Add-On Specialized lab panel with additional biomarkers for reproductive age and hormonal health including Anti-Tg, C-Peptide, Prolactin, and Selenium, priced at $59 annually. Designed for women seeking deeper hormonal insight layered on the core membership.
• Life-Stage Focus: Perimenopause Add-On Specialized lab panel for perimenopause detection including Osteocalcin and Pregnenolone biomarkers, bundled with a Perimenopause Stage Assessment tool, priced at $129 annually. Designed for women navigating the perimenopause transition.
• Life-Stage Focus: Preconception & Fertility Add-On Comprehensive fertility panel including Iodine, CoQ10, Inhibin B, and Anti-Müllerian Hormone (AMH), bundled with a Personal Fertility Timeline Assessment, priced at $299 annually. Designed for women planning pregnancy or evaluating fertility status.
• Mobile Phlebotomy Add-On On-demand mobile phlebotomy service where a phlebotomist comes to the member's home or office for sample collection, priced at $105 as a one-time add-on. Designed for members seeking convenience over visiting Quest Diagnostics or LabCorp collection sites.
• AI Health Companion 24/7 AI-powered chatbot and support system integrated into the Xella platform providing on-demand health guidance and biomarker interpretation. Designed for members seeking continuous on-demand support alongside clinician-reviewed AI insights.

Quantifiable outcome

• 130+ female-specific conditions screened through comprehensive biomarker analysis
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Quest DiagnosticscoreTechnology or IntegrationLaboratory partner providing blood draw sample collection at 2000+ locations nationwide. Samples processed in CLIA-certified and CAP-accredited laboratories.
• LabCorpcoreTechnology or IntegrationLaboratory partner providing blood draw sample collection at 2000+ locations nationwide. Samples processed in CLIA-certified and CAP-accredited laboratories.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Everlywell: Everlywell is a DTC at-home lab testing platform offering panels across hormones, fertility, thyroid, and metabolic health. It competes with Xella in the consumer lab testing space with broader but shallower panels.
• Tia: Tia is a women's primary care platform combining in-person clinics with virtual care across gynecology, mental health, and primary care. It overlaps directly with Xella's perimenopause, hormonal, and gynecologic concern segments and competes for the same proactive health-conscious woman customer.
• Kindbody: Kindbody is a fertility and women's health clinic network with employer benefits and DTC offerings. Xella's clinical advisory board includes Kindbody's CMO, and both target fertility, perimenopause, and hormonal health — making Kindbody a directly comparable peer.
• Thorne: Thorne is a DTC health testing and supplements platform offering at-home biomarker tests and personalized recommendations. Comparable in consumer-facing precision health testing, though Thorne emphasizes supplements and wellness rather than clinician-led care.
• Hers (Hims & Hers Health): Hers is the women's health vertical of Hims & Hers, providing DTC telehealth, prescription medications, and over-the-counter products for women's conditions including hair, skin, mental health, and sexual health. Comparable in DTC women's health subscription model.
• Ro: Ro is a direct-to-consumer healthcare platform offering virtual care and pharmacy across multiple conditions including women's health, fertility, and weight management. It is comparable to Xella in DTC telehealth-plus-prescription model, though Ro operates across broader conditions.
• Maven Clinic: Maven Clinic is a virtual women's and family health platform offering care across fertility, pregnancy, postpartum, and menopause. It is directly comparable to Xella in serving women across reproductive life stages with virtual clinician-led care, though its core modality is virtual visits rather than multi-omic diagnostics.
• Function Health: Function Health is a DTC comprehensive lab testing platform analyzing 100+ biomarkers annually with clinician-reviewed results. It is one of the most direct competitors to Xella in the multi-omic DTC lab testing category, though Function Health is currently sex-agnostic.
• Midi Health: Midi Health is a virtual care clinic focused specifically on women in perimenopause and menopause, offering clinician-led care, hormone therapy, and personalized treatment. It is a direct competitor to Xella in the perimenopause/menopause care segment.

Emerging players

• Levels: Levels is a continuous metabolic health monitoring platform using CGMs with AI-driven insights. It overlaps with Xella in AI-powered metabolic biomarker analysis and proactive health consumer positioning, but is narrower in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/xella-health
• Facebookfacebook.com/profile.php

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xella Health